Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,440
-10 (-0.09%)
Nov 18, 2024, 3:19 PM KST

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 263.27 billion as of November 18, 2024. Its market cap has decreased by -30.68% in one year.

Market Cap
263.27B
Enterprise Value
216.43B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
11,440.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 263.27B, an increase of 64.30%. That is a compound annual growth rate of 12.71%.

History

DateMarket Cap% Change
Nov 15, 2024263.27B-49.00%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 20202,517.20B1,470.89%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition